We founded the Swiss Ventures Group because the wealth of experience we have accumulated over the years is meant to be shared. Check out our news and find extensive background information on investments, startups and the world of VC.
Our Serpentine Ventures portfolio companies, Properti AG, Isochronic AG and Auxivo AG were recognized as being part of the TOP 100 Swiss Startup Awards 2023. Congratulations and we remain committed to supporting their continued success.
Piomic, our Swiss Diabetes Venture Fund portfolio company, enrolls first patients in MAVERICKS U.S. study after Medicare Category B designation. FDA-approved IDE study sets groundwork for device authorization and commercialization.
Discover the insights in Partners Group's white paper: Private Markets - The New Traditional Asset Class. Explore how private and public markets are redefining the role of financing in the real economy.
Our Venture Asset Management Program with IMD is happening next week on Aug 31 - Sep 1. Two days of deep learning and fully booked with enthusiastic participants, reflecting our commitment to shaping the future of Venture Asset Management.